ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Monoclonal Antibodies - The Challenges in Drug Development
July 28, 2020Monoclonal antibodies (mAb) are approved in a wide range of conditions and represent the largest class of biotherapeutic products. mAbs are large molecules with complex structures and functions. -
Inhibrx Announces Dosing of First Patient in Phase 1 Dose-Escalation Study of INBRX-105
February 20, 2019Inhibrx announced dosing has begun in a Phase 1 dose-escalation clinical trial of INBRX-105. INBRX-105 is a novel, multispecific antibody therapeutic candidate that is both an antagonist of PD-L1 and .....
Pharma Sources Insight January 2025
